A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)

Trial Profile

A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder (OAB)

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 Oct 2017

At a glance

  • Drugs Mirabegron (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms PERSPECTIVE
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 17 Oct 2017 Status changed from active, no longer recruiting to completed.
    • 29 Jun 2017 Planned End Date changed from 1 Jul 2017 to 1 Aug 2017.
    • 29 Jun 2017 Planned primary completion date changed from 1 Jul 2017 to 1 Aug 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top